Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,213 across all filing types
Latest filing 2023-01-30 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors regarding the approval for drug production and registration of a specific product. It is not a financial report, earnings release, or regulatory filing related to financial performance. The document is short (1773 characters) and serves to inform shareholders and investors about a business development update. It does not contain financial statements or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2023-01-30 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT AND BUSINESS DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the company's board providing updates on product development and business development, including regulatory approvals and inclusion of products in a national drug list. It does not contain financial statements, detailed financial analysis, or regulatory certifications. The length is short (2834 characters), and it is clearly an announcement to inform shareholders and investors about business progress rather than a formal report or filing. There is no indication of it being an earnings release, annual or interim report, or any other formal regulatory filing. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2023-01-19 English
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 13 JANUARY 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from an Extraordinary General Meeting (EGM) held on 13 January 2023. It details the voting outcomes on specific resolutions related to the adoption of a new share option scheme and service provider sublimit. The text includes the number of shares voted for and against each resolution and confirms that all resolutions were passed. There is no detailed financial data, management discussion, or full report content. The document is short (3980 characters) and serves as an official announcement of voting results rather than the meeting materials or the full report itself. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-01-13 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
Regulatory Filings Classification · 90% confidence The document is a voluntary announcement by the board of directors of SSY Group Limited regarding recognition of a subsidiary as a Technology Innovation Demonstration Enterprise and a project recognized as an Industrial Internet Innovative Development Pilot Project. It is an update on business development and does not contain financial statements, audit information, or detailed management discussion. The document is relatively short (2552 characters) and serves to inform shareholders and investors about recent business developments rather than presenting financial results or formal reports. It is not an Annual Report, Interim Report, Earnings Release, or any regulatory filing. It is also not a report publication announcement since it contains substantive content rather than just a notice of report availability. The content fits best under a general business update or announcement category. Given the available categories, the closest match is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other specific categories.
2023-01-09 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for SSY Group Limited. It includes detailed information about repurchase of shares, cancellation, and confirmations related to share capital changes. The document references specific listing rules from the Stock Exchange of Hong Kong and provides detailed disclosures about share repurchases and issued shares. This type of document is a regulatory disclosure about share capital changes, specifically share repurchases and cancellations, which fits the category of Transaction in Own Shares (POS). It is not an announcement of a report, nor a full financial report, but a regulatory filing about share transactions by the company itself.
2023-01-05 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT AND BUSINESS DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement from the board of directors providing updates on product development and business development, including approvals for drug production and recognition of quality benchmarks. It does not contain financial statements, detailed financial analysis, or regulatory filings such as annual or quarterly reports. The document is relatively short (2556 characters) and serves to inform shareholders and investors about recent business progress rather than presenting formal financial results or governance changes. It is not an announcement of voting results, nor does it relate to capital changes, mergers, or legal proceedings. Therefore, it fits best under the category of a general regulatory announcement or miscellaneous filing that does not fit other specific categories, which corresponds to Regulatory Filings (RNS).
2023-01-05 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.